Barclays
CC icon

Barclays’s Chemours CC Stock Holding History

Barclays’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-234,800
Closed -$6.17M – 4914
2024
Q1 		$6.17M Buy
+234,800
New +$6.69M ﹤0.01% 1717
2022
Q1 		– Sell
-207,100
Closed -$6.95M – 4998
2021
Q4 		$6.95M Buy
207,100
+2,700
+1% +$84.1K ﹤0.01% 1484
2021
Q3 		$5.94M Buy
204,400
+4,400
+2% +$142K ﹤0.01% 1509
2021
Q2 		$6.96M Buy
+200,000
New +$6.62M ﹤0.01% 1398
2021
Q1 		– Sell
-2,000
Closed -$50K – 4733
2020
Q4 		$50K Buy
2,000
+1,000
+100% +$23.8K ﹤0.01% 4396
2020
Q3 		$21K Hold
1,000
– – ﹤0.01% 4890
2020
Q2 		$15K Sell
1,000
-1,000
-50% -$12.6K ﹤0.01% 5256
2020
Q1 		$18K Sell
2,000
-2,800
-58% -$40.4K ﹤0.01% 5668
2019
Q4 		$87K Sell
4,800
-6,800
-59% -$113K ﹤0.01% 5538
2019
Q3 		$173K Buy
11,600
+4,400
+61% +$71.6K ﹤0.01% 5075
2019
Q2 		$173K Sell
7,200
-20,800
-74% -$613K ﹤0.01% 5248
2019
Q1 		$1.04M Sell
28,000
-11,400
-29% -$415K ﹤0.01% 3357
2018
Q4 		$1.11M Buy
39,400
+19,200
+95% +$607K ﹤0.01% 2998
2018
Q3 		$797K Buy
20,200
+400
+2% +$17.5K ﹤0.01% 3854
2018
Q2 		$879K Buy
19,800
+2,900
+17% +$144K ﹤0.01% 3425
2018
Q1 		$823K Buy
16,900
+14,000
+483% +$700K ﹤0.01% 3446
2017
Q4 		$145K Sell
2,900
-1,700
-37% -$89K ﹤0.01% 4949
2017
Q3 		$233K Buy
4,600
+800
+21% +$37.7K ﹤0.01% 4295
2017
Q2 		$144K Buy
3,800
+1,600
+73% +$63.1K ﹤0.01% 4635
2017
Q1 		$85K Sell
2,200
-1,660
-43% -$50K ﹤0.01% 5003
2016
Q4 		$85K Buy
3,860
+2,200
+133% +$45.2K ﹤0.01% 4861
2016
Q3 		$27K Hold
1,660
– – ﹤0.01% 5313
2016
Q2 		$14K Hold
1,660
– – ﹤0.01% 5414
2016
Q1 		$12K Sell
1,660
-32,540
-95% -$164K ﹤0.01% 5409
2015
Q4 		$171K Sell
34,200
-10,960
-24% -$70K ﹤0.01% 4026
2015
Q3 		$271K Buy
+45,160
New +$473K ﹤0.01% 3896

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Barclays's CC Position: Q2 2026 in Review

Barclays reduced its Chemours (CC) stake by 23% in Q2 2026, selling an estimated $170K and leaving 25,509 shares worth $523K. The position accounts for ﹤0.01% of the portfolio, ranked #3193.

Barclays first reported a position in CC in Q3 2015 and has held it in 44 quarters since. The position peaked at $14.8M in Q3 2025. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Barclays held 25,509 shares of Chemours worth $523K as of Q2 2026.
  • Barclays sold 7,447 Chemours shares in Q2 2026, an estimated $170K.
  • Chemours made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3193 holding.
  • Barclays first reported a position in Chemours in Q3 2015 and has held it in 44 quarters since.
  • Barclays's Chemours position peaked at $14.8M in Q3 2025.
  • 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.